Search Within

Alumni (GSK)

  1. "Clinical Genetics Service"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (21)
  3. Correspondence (1)
  4. Editorial (1)
Groups
  1. Clinical Genetics Service (54)
  2. Department of Medicine (54)
  3. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (54)
  4. Population Sciences Research Program (54)
  5. Solid Tumor Oncology Division (54)
  6. GSK Faculty (49)

More Groups

People
  1. Semanti Mukherjee (50)
  2. Kenneth Offit (43)
  3. Vijai Joseph (27)
  4. Zsofia Stadler (26)
  5. Mark Robson (25)
  6. Yelena Kemel (25)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (5)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Cancer Research (6)
  3. JCO Precision Oncology (4)
  4. Clinical Cancer Research (3)
  5. Cancer Discovery (2)
  6. Cancer Epidemiology Biomarkers and Prevention (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. American Association for Cancer Research (13)
  3. Nature Publishing Group (6)
  4. American Medical Association (3)
  5. Cell Press (2)
  6. Elsevier Inc. (2)

More Publishers

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
    Journal Article

    Cadoo, K. A.; Mandelker, D. L.; Mukherjee, S.; Stewart, C.; DeLair, D.; Ravichandran, V.; Srinivasan, P.; Hurley, D.; Kemel, Y.; Arnold, A. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Germline RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in homologous recombination deficient tumors
    Meeting Abstract

    Mandelker, D.; Mukherjee, S.; Setton, J.; Cadoo, K.; Selenica, P.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; Tkachuk, K.; Brown, D.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Inherited truncating RAD52 variant discovered using integrated germline-somatic analysis predicts clinical outcome in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Srinivasan, P.; Bandlamudi, C.; Hellmann, M. D.; Ravichandran, V.; Selvan, M. E.; Kemel, Y.; Mandelker, D.; Zauderer, M.; Walsh, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Zygosity, lineage, and penetrance dictate the role of germline pathogenicity in tumorigenesis
    Meeting Abstract

    Bandlamudi, C.; Srinivasan, P.; Jonsson, P.; Kemel, Y. M.; Chavan, S. S.; Richards, A. L.; Penson, A.; Bielski, C. M.; Fong, C.; Syed, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CHEK2 alleles predispose to renal cancer in Poland - In reply
    Correspondence

    Carlo, M. I.; Mukherjee, S.; Offit, K.
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Frequency of actionable cancer predisposing germline mutations in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Preclinical evaluation of enhanced irofulven antitumor activity in an ERCC3 mutant background by in vitro and in vivo tumor models
    Meeting Abstract

    Topka, S.; Khalil, S.; De Stanchina, E.; Vijai, J.; Offit, K.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability
    Journal Article

    Raj, N.; Shah, R.; Stadler, Z.; Mukherjee, S.; Chou, J.; Untch, B.; Li, J.; Kelly, V.; Osoba, M.; Saltz, L. B.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC)
    Meeting Abstract

    Ku, G. Y.; Mukherjee, S.; Okoro, C.; Sharma, M.; Ravichandran, V.; Offit, K.; Joseph, V.; Janjigian, Y. Y.; Stadler, Z. K.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save